Oral Communication

Long Acting injectables: the Italian experience

OC 9
One-year of long-acting cabotegravir and rilpivirine in people with HIV and a long exposure to antiretroviral therapy: data from the SCohoLART study

OC 10
Effectiveness of long-acting ART with cabotegravir/rilpivirine in the Icona Cohort

OC 11
Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

OC 12
Pittsburgh sleep quality index (PSQI) changes in virologically suppressed people living with HIV switching to long acting cabotegravir and rilpivirine

×

Commento audio

Chiudi